SCHEMBL14690308

SCHEMBL14690308

C=CC(=O)Oc1ccc(N=Nc2ccccc2OC(=O)C=C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 4/20 0.41
▸ THRA P10827 1/20 0.41
▸ ELANE P08246 1/20 0.41
▸ IDE P14735 1/20 0.38
▸ MYC P01106 1/20 0.35
▸ PDE6D O43924 1/20 0.34
▸ ADRB2 P07550 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ TRPA1 O75762 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ L3MBTL1 Q9Y468 4/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TYMS P04818 1/20 0.34
▸ RAB9A P51151 3/20 0.33
▸ NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14690310 1.00 THRB (0.41) THRBTHRAELANEIDEMYC
SCHEMBL4328150 0.91 THRB (0.43) THRBTHRAIDEMYCMAPT
SCHEMBL4328153 0.91 THRB (0.43) THRBTHRAIDEMYCMAPT
SCHEMBL28862973 0.90 KMT2A (0.46) THRBTHRAELANEMAPTHPGD
SCHEMBL14689897 0.89 THRB (0.48) THRBTHRAMAPTKDM4EHPGD
SCHEMBL14689896 0.89 THRB (0.48) THRBTHRAMAPTKDM4EHPGD
SCHEMBL28110513 0.89 MEN1 (0.43) THRBTHRAIDEMYCADRB2
SCHEMBL27924225 0.87 TRPA1 (0.53) THRBTHRAIDEMYCMAPT
SCHEMBL28862957 0.87 CYP11B1 (0.38) THRBTHRAELANEIDEMEN1
SCHEMBL4328157 0.84 TRPA1 (0.48) THRBELANEPDE6DMAPTTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890351-B2 Encapsulates THE PROCTER & GAMBLE COMPANY (US) 2018-02-13 — — US disclosed
EP-2741731-B1 ENCAPSULATES PROCTER & GAMBLE (US) 2017-05-17 — — EP disclosed
EP-2741731-A1 ENCAPSULATES The Procter and Gamble Company (US) 2014-06-18 — — EP disclosed
US-20130039962-A1 ENCAPSULATES ENCAPSYS, LLC 2013-02-14 — — US disclosed
WO-2013022949-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY (US) 2013-02-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130039962-A1 ENCAPSULATES ABCB4, PPIB, FLNB THRB 4585/4885THRA 4860/4885ELANE 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback